Skip to content
healthcare.dev

Pitavastatin

NDC 65862-814, Pitavastatin, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-814
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PITAVASTATIN CALCIUM4 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
65862-814-0565862081405500 TABLET, FILM COATED in 1 BOTTLE (65862-814-05)
65862-814-906586208149090 TABLET, FILM COATED in 1 BOTTLE (65862-814-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a52401eb-a822-475b-a40d-7b8acde2ae1a
  • NADAC price for package 65862081490

    GET /v1/drugs/nadac/65862081490

Use it

Look up 65862-814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.